Copyright Reports & Markets. All rights reserved.

Global Livestock Animal Vaccination Market Research Report 2022

Buy now

1 Livestock Animal Vaccination Market Overview

  • 1.1 Product Overview and Scope of Livestock Animal Vaccination
  • 1.2 Livestock Animal Vaccination Segment by Type
  • 1.2.1 Global Livestock Animal Vaccination Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Live Attenuated Vaccines
  • 1.2.3 Inactivated Vaccines
  • 1.2.4 Other
  • 1.3 Livestock Animal Vaccination Segment by Application
  • 1.3.1 Global Livestock Animal Vaccination Sales Comparison by Application: (2022-2028)
  • 1.3.2 Pig
  • 1.3.3 Cattle
  • 1.3.4 Poultry
  • 1.3.5 Other
  • 1.4 Global Livestock Animal Vaccination Market Size Estimates and Forecasts
  • 1.4.1 Global Livestock Animal Vaccination Revenue 2017-2028
  • 1.4.2 Global Livestock Animal Vaccination Sales 2017-2028
  • 1.4.3 Livestock Animal Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Livestock Animal Vaccination Market Competition by Manufacturers

    • 2.1 Global Livestock Animal Vaccination Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Livestock Animal Vaccination Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Livestock Animal Vaccination Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Livestock Animal Vaccination Manufacturing Sites, Area Served, Product Type
    • 2.5 Livestock Animal Vaccination Market Competitive Situation and Trends
    • 2.5.1 Livestock Animal Vaccination Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Livestock Animal Vaccination Players Market Share by Revenue
  • 2.5.3 Global Livestock Animal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Livestock Animal Vaccination Retrospective Market Scenario by Region

    • 3.1 Global Livestock Animal Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Livestock Animal Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Livestock Animal Vaccination Market Facts & Figures by Country
    • 3.3.1 North America Livestock Animal Vaccination Sales by Country
  • 3.3.2 North America Livestock Animal Vaccination Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Livestock Animal Vaccination Market Facts & Figures by Country
  • 3.4.1 Europe Livestock Animal Vaccination Sales by Country
  • 3.4.2 Europe Livestock Animal Vaccination Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Livestock Animal Vaccination Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Livestock Animal Vaccination Sales by Region
  • 3.5.2 Asia Pacific Livestock Animal Vaccination Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Livestock Animal Vaccination Market Facts & Figures by Country
  • 3.6.1 Latin America Livestock Animal Vaccination Sales by Country
  • 3.6.2 Latin America Livestock Animal Vaccination Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.7 Middle East and Africa Livestock Animal Vaccination Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Livestock Animal Vaccination Sales by Country
  • 3.7.2 Middle East and Africa Livestock Animal Vaccination Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Livestock Animal Vaccination Historic Market Analysis by Type

    • 4.1 Global Livestock Animal Vaccination Sales Market Share by Type (2017-2022)
    • 4.2 Global Livestock Animal Vaccination Revenue Market Share by Type (2017-2022)
    • 4.3 Global Livestock Animal Vaccination Price by Type (2017-2022)

    5 Global Livestock Animal Vaccination Historic Market Analysis by Application

    • 5.1 Global Livestock Animal Vaccination Sales Market Share by Application (2017-2022)
    • 5.2 Global Livestock Animal Vaccination Revenue Market Share by Application (2017-2022)
    • 5.3 Global Livestock Animal Vaccination Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Merck
    • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Merck Livestock Animal Vaccination Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
  • 6.2 Zoetis
  • 6.2.1 Zoetis Corporation Information
  • 6.2.2 Zoetis Description and Business Overview
  • 6.2.3 Zoetis Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Zoetis Livestock Animal Vaccination Product Portfolio
  • 6.2.5 Zoetis Recent Developments/Updates
  • 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Corporation Information
  • 6.3.2 Boehringer Ingelheim Description and Business Overview
  • 6.3.3 Boehringer Ingelheim Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Boehringer Ingelheim Livestock Animal Vaccination Product Portfolio
  • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.4 Ceva
  • 6.4.1 Ceva Corporation Information
  • 6.4.2 Ceva Description and Business Overview
  • 6.4.3 Ceva Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Ceva Livestock Animal Vaccination Product Portfolio
  • 6.4.5 Ceva Recent Developments/Updates
  • 6.5 CAHIC
  • 6.5.1 CAHIC Corporation Information
  • 6.5.2 CAHIC Description and Business Overview
  • 6.5.3 CAHIC Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 CAHIC Livestock Animal Vaccination Product Portfolio
  • 6.5.5 CAHIC Recent Developments/Updates
  • 6.6 HVRI
  • 6.6.1 HVRI Corporation Information
  • 6.6.2 HVRI Description and Business Overview
  • 6.6.3 HVRI Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 HVRI Livestock Animal Vaccination Product Portfolio
  • 6.6.5 HVRI Recent Developments/Updates
  • 6.7 Ringpu Biology
  • 6.6.1 Ringpu Biology Corporation Information
  • 6.6.2 Ringpu Biology Description and Business Overview
  • 6.6.3 Ringpu Biology Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Ringpu Biology Livestock Animal Vaccination Product Portfolio
  • 6.7.5 Ringpu Biology Recent Developments/Updates
  • 6.8 Yebio
  • 6.8.1 Yebio Corporation Information
  • 6.8.2 Yebio Description and Business Overview
  • 6.8.3 Yebio Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Yebio Livestock Animal Vaccination Product Portfolio
  • 6.8.5 Yebio Recent Developments/Updates
  • 6.9 DHN
  • 6.9.1 DHN Corporation Information
  • 6.9.2 DHN Description and Business Overview
  • 6.9.3 DHN Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 DHN Livestock Animal Vaccination Product Portfolio
  • 6.9.5 DHN Recent Developments/Updates
  • 6.10 WINSUN
  • 6.10.1 WINSUN Corporation Information
  • 6.10.2 WINSUN Description and Business Overview
  • 6.10.3 WINSUN Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 WINSUN Livestock Animal Vaccination Product Portfolio
  • 6.10.5 WINSUN Recent Developments/Updates
  • 6.11 Elanco
  • 6.11.1 Elanco Corporation Information
  • 6.11.2 Elanco Livestock Animal Vaccination Description and Business Overview
  • 6.11.3 Elanco Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 Elanco Livestock Animal Vaccination Product Portfolio
  • 6.11.5 Elanco Recent Developments/Updates
  • 6.12 Jinyu Bio-Technology
  • 6.12.1 Jinyu Bio-Technology Corporation Information
  • 6.12.2 Jinyu Bio-Technology Livestock Animal Vaccination Description and Business Overview
  • 6.12.3 Jinyu Bio-Technology Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Jinyu Bio-Technology Livestock Animal Vaccination Product Portfolio
  • 6.12.5 Jinyu Bio-Technology Recent Developments/Updates
  • 6.13 ChengDu Tecbond
  • 6.13.1 ChengDu Tecbond Corporation Information
  • 6.13.2 ChengDu Tecbond Livestock Animal Vaccination Description and Business Overview
  • 6.13.3 ChengDu Tecbond Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 ChengDu Tecbond Livestock Animal Vaccination Product Portfolio
  • 6.13.5 ChengDu Tecbond Recent Developments/Updates
  • 6.14 CAVAC
  • 6.14.1 CAVAC Corporation Information
  • 6.14.2 CAVAC Livestock Animal Vaccination Description and Business Overview
  • 6.14.3 CAVAC Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 CAVAC Livestock Animal Vaccination Product Portfolio
  • 6.14.5 CAVAC Recent Developments/Updates
  • 6.15 Kyoto Biken Laboratories
  • 6.15.1 Kyoto Biken Laboratories Corporation Information
  • 6.15.2 Kyoto Biken Laboratories Livestock Animal Vaccination Description and Business Overview
  • 6.15.3 Kyoto Biken Laboratories Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.15.4 Kyoto Biken Laboratories Livestock Animal Vaccination Product Portfolio
  • 6.15.5 Kyoto Biken Laboratories Recent Developments/Updates
  • 6.16 FATRO
  • 6.16.1 FATRO Corporation Information
  • 6.16.2 FATRO Livestock Animal Vaccination Description and Business Overview
  • 6.16.3 FATRO Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.16.4 FATRO Livestock Animal Vaccination Product Portfolio
  • 6.16.5 FATRO Recent Developments/Updates
  • 6.17 Vaksindo
  • 6.17.1 Vaksindo Corporation Information
  • 6.17.2 Vaksindo Livestock Animal Vaccination Description and Business Overview
  • 6.17.3 Vaksindo Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.17.4 Vaksindo Livestock Animal Vaccination Product Portfolio
  • 6.17.5 Vaksindo Recent Developments/Updates
  • 6.18 Bio-Labs
  • 6.18.1 Bio-Labs Corporation Information
  • 6.18.2 Bio-Labs Livestock Animal Vaccination Description and Business Overview
  • 6.18.3 Bio-Labs Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.18.4 Bio-Labs Livestock Animal Vaccination Product Portfolio
  • 6.18.5 Bio-Labs Recent Developments/Updates
  • 6.19 MEVAC
  • 6.19.1 MEVAC Corporation Information
  • 6.19.2 MEVAC Livestock Animal Vaccination Description and Business Overview
  • 6.19.3 MEVAC Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.19.4 MEVAC Livestock Animal Vaccination Product Portfolio
  • 6.19.5 MEVAC Recent Developments/Updates
  • 6.20 Biovac
  • 6.20.1 Biovac Corporation Information
  • 6.20.2 Biovac Livestock Animal Vaccination Description and Business Overview
  • 6.20.3 Biovac Livestock Animal Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 6.20.4 Biovac Livestock Animal Vaccination Product Portfolio
  • 6.20.5 Biovac Recent Developments/Updates
  • 7 Livestock Animal Vaccination Manufacturing Cost Analysis

    • 7.1 Livestock Animal Vaccination Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Livestock Animal Vaccination
  • 7.4 Livestock Animal Vaccination Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Livestock Animal Vaccination Distributors List
    • 8.3 Livestock Animal Vaccination Customers

    9 Livestock Animal Vaccination Market Dynamics

    • 9.1 Livestock Animal Vaccination Industry Trends
    • 9.2 Livestock Animal Vaccination Market Drivers
    • 9.3 Livestock Animal Vaccination Market Challenges
    • 9.4 Livestock Animal Vaccination Market Restraints

    10 Global Market Forecast

    • 10.1 Livestock Animal Vaccination Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Livestock Animal Vaccination by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Livestock Animal Vaccination by Type (2023-2028)
  • 10.2 Livestock Animal Vaccination Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Livestock Animal Vaccination by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Livestock Animal Vaccination by Application (2023-2028)
  • 10.3 Livestock Animal Vaccination Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Livestock Animal Vaccination by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Livestock Animal Vaccination by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for Livestock animals.
      Industry Insights

      Due to the COVID-19 pandemic, the global Livestock Animal Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Livestock Animal Vaccination market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Livestock Animal Vaccination landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

      Live Attenuated Vaccines accounting for % of the Livestock Animal Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pig segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

      The global major manufacturers of Livestock Animal Vaccination include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In terms of revenue, the global 3 largest players have a % market share of Livestock Animal Vaccination in 2021.

      This report focuses on Livestock Animal Vaccination volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Livestock Animal Vaccination market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

      Key Drivers & Barriers

      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

      Post-covid-19 Outlook

      The readers in the section will understand how the Livestock Animal Vaccination market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

      Segmental Outlook

      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

      Segment by Type

      Live Attenuated Vaccines

      Inactivated Vaccines

      Other

      Segment by Application

      Pig

      Cattle

      Poultry

      Other

      Regional Outlook

      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

      North America

      United States

      Canada

      Europe

      Germany

      France

      U.K.

      Italy

      Russia

      Asia-Pacific

      China

      Japan

      South Korea

      India

      Australia

      China Taiwan

      Indonesia

      Thailand

      Malaysia

      Latin America

      Mexico

      Brazil

      Argentina

      Middle East & Africa

      Turkey

      Saudi Arabia

      UAE

      Competitive Scenario

      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

      Merck

      Zoetis

      Boehringer Ingelheim

      Ceva

      CAHIC

      HVRI

      Ringpu Biology

      Yebio

      DHN

      WINSUN

      Elanco

      Jinyu Bio-Technology

      ChengDu Tecbond

      CAVAC

      Kyoto Biken Laboratories

      FATRO

      Vaksindo

      Bio-Labs

      MEVAC

      Biovac

      Frequently Asked Questions

      Which product segment grabbed the largest share in the Livestock Animal Vaccination market?

      How is the competitive scenario of the Livestock Animal Vaccination market?

      Which are the key factors aiding the Livestock Animal Vaccination market growth?

      Which are the prominent players in the Livestock Animal Vaccination market?

      Which region holds the maximum share in the Livestock Animal Vaccination market?

      What will be the CAGR of the Livestock Animal Vaccination market during the forecast period?

      Which application segment emerged as the leading segment in the Livestock Animal Vaccination market?

      What key trends are likely to emerge in the Livestock Animal Vaccination market in the coming years?

      What will be the Livestock Animal Vaccination market size by 2028?

      Which company held the largest share in the Livestock Animal Vaccination market?

      Buy now